«Just 44 percent of
the pediatric cancer driver mutations in this study matched those identified in adults,» said senior author Jinghui Zhang, PhD, St. Jude Computational Biology chair.
E. Intensify research on the major
drivers of childhood
cancers Improve our understanding of fusion oncoproteins in
pediatric cancer and use new preclinical models to develop inhibitors that target them.